カテゴリー： QYResearch, 世界

エゼチミブの世界市場動向・分析2018-2025

【英語タイトル】Global Ezetimibe Industry Research Report, Growth Trends and Competitive Analysis 2018-2025

QYResearchが出版した調査資料（QYR8D03662）・商品コード：QYR8D03662
・発行会社（調査会社）：QYResearch
・発行日：2018年11月12日
・ページ数：116
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル、世界主要国
・産業分野：製薬・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥627,200見積依頼/購入/質問フォーム
Enterprise（同一法人内共有可）USD9,800 ⇒換算￥1,254,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、エゼチミブの世界市場について調査・分析し、種類別には、10mgタブレット、タイプIIに、用途別には、大人、子ども(10-17歳)に区分してまとめました。調査対象企業は、Merck、Teva、Zydus Pharmaceuticals、Amneal Pharmaceuticals、Alkem Laboratories、APOTEX、Sandoz、Glenmark Pharmaceuticals、Mylan Pharmaceuticals、Aurobindo Pharma、Accord Healthcare等です。

・レポートの概要
・グローバル成長トレンド
・エゼチミブの世界市場規模
・エゼチミブの地域別市場規模
・グローバル産業動向
・企業別市場シェア
・企業別エゼチミブの価格動向
・エゼチミブの種類別市場規模（10mgタブレット、タイプII）
・エゼチミブの用途別市場規模（大人、子ども(10-17歳)）
・エゼチミブの北米市場（アメリカ、カナダ、メキシコ）
・エゼチミブのヨーロッパ市場（ドイツ、フランス、イギリス、イタリア、ロシア）
・エゼチミブのアジア市場（日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム）
・エゼチミブの中南米市場（ブラジル等）
・エゼチミブの中東・アフリカ市場（GCC、エジプト、南アフリカ）
・主要企業情報（Merck、Teva、Zydus Pharmaceuticals、Amneal Pharmaceuticals、Alkem Laboratories、APOTEX、Sandoz、Glenmark Pharmaceuticals、Mylan Pharmaceuticals、Aurobindo Pharma、Accord Healthcare）
　－企業概要、事業概要、販売・売上・市場シェア、XXX製品概要、企業動向
・バリューチェーン及び販売チャネル分析
・エゼチミブの市場規模予測
・エゼチミブの種類別市場予測2018-2025（10mgタブレット、タイプII）
・エゼチミブの用途別市場予測2018-2025（大人、子ども(10-17歳)）
・エゼチミブの北米市場予測2018-2025（アメリカ、カナダ、メキシコ）
・エゼチミブのヨーロッパ市場予測2018-2025（ドイツ、フランス、イギリス、イタリア、ロシア）
・エゼチミブのアジア市場予測2018-2025（日本、中国、韓国、インド、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、ベトナム）
・エゼチミブの中南米市場予測2018-2025（ブラジル等）
・エゼチミブの中東・アフリカ市場予測2018-2025（GCC、エジプト、南アフリカ）
・調査結果及び結論
【レポートの概要】

Ezetimibe is a drug that lowers plasma cholesterol levels. It acts by decreasing cholesterol absorption in the small intestine. It may be used alone (marketed as Zetia or Ezetrol), when other cholesterol-lowering medications are not tolerated, or together with statins (e.g., ezetimibe/simvastatin, marketed as Vytorin or Inegy) when statins alone do not control cholesterol.In 2018, the global Ezetimibe market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Ezetimibe.

This study researches the market size of Ezetimibe, presents the global Ezetimibe sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
This report focuses on the key data information of Ezetimibe in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Ezetimibe for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Merck
Teva
Zydus Pharmaceuticals
Amneal Pharmaceuticals
Alkem Laboratories
APOTEX
Sandoz
Glenmark Pharmaceuticals
Mylan Pharmaceuticals
Aurobindo Pharma
Accord Healthcare

Market Segment by Product Type
10 mg tablet
Type II

Market Segment by Application
Adult
Children(10-17 years)

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Ezetimibe status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Ezetimibe manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Ezetimibe are as follows:
History Year: 2013-2018
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Ezetimibe Market Size Growth Rate by Type
1.3.2 10 mg tablet
1.3.3 Type II
1.4 Market Segment by Application
1.4.1 Global Ezetimibe Market Share by Application (2018-2025)
1.4.2 Adult
1.4.3 Children(10-17 years)
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Ezetimibe Market Size
2.1.1 Global Ezetimibe Revenue 2013-2025
2.1.2 Global Ezetimibe Sales 2013-2025
2.2 Ezetimibe Growth Rate by Regions
2.2.1 Global Ezetimibe Sales by Regions 2013-2018
2.2.2 Global Ezetimibe Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Ezetimibe Sales by Manufacturers
3.1.1 Ezetimibe Sales by Manufacturers 2013-2018
3.1.2 Ezetimibe Sales Market Share by Manufacturers 2013-2018
3.2 Revenue by Manufacturers
3.2.1 Ezetimibe Revenue by Manufacturers (2013-2018)
3.2.2 Ezetimibe Revenue Share by Manufacturers (2013-2018)
3.2.3 Global Ezetimibe Market Concentration Ratio (CR5 and HHI)
3.3 Ezetimibe Price by Manufacturers
3.4 Key Manufacturers Ezetimibe Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Ezetimibe Market
3.6 Key Manufacturers Ezetimibe Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 10 mg tablet Sales and Revenue (2013-2018)
4.1.2 Type II Sales and Revenue (2013-2018)
4.2 Global Ezetimibe Sales Market Share by Type
4.3 Global Ezetimibe Revenue Market Share by Type
4.4 Ezetimibe Price by Type

5 Market Size by Application
5.1 Overview
5.2 Global Ezetimibe Sales by Application

6 North America
6.1 North America Ezetimibe Breakdown Data by Company
6.2 North America Ezetimibe Breakdown Data by Type
6.3 North America Ezetimibe Breakdown Data by Application
6.4 North America Ezetimibe Breakdown Data by Countries
6.4.1 North America Ezetimibe Sales by Countries
6.4.2 North America Ezetimibe Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Ezetimibe Breakdown Data by Company
7.2 Europe Ezetimibe Breakdown Data by Type
7.3 Europe Ezetimibe Breakdown Data by Application
7.4 Europe Ezetimibe Breakdown Data by Countries
7.4.1 Europe Ezetimibe Sales by Countries
7.4.2 Europe Ezetimibe Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Ezetimibe Breakdown Data by Company
8.2 Asia Pacific Ezetimibe Breakdown Data by Type
8.3 Asia Pacific Ezetimibe Breakdown Data by Application
8.4 Asia Pacific Ezetimibe Breakdown Data by Countries
8.4.1 Asia Pacific Ezetimibe Sales by Countries
8.4.2 Asia Pacific Ezetimibe Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Thailand
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Ezetimibe Breakdown Data by Company
9.2 Central & South America Ezetimibe Breakdown Data by Type
9.3 Central & South America Ezetimibe Breakdown Data by Application
9.4 Central & South America Ezetimibe Breakdown Data by Countries
9.4.1 Central & South America Ezetimibe Sales by Countries
9.4.2 Central & South America Ezetimibe Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Ezetimibe Breakdown Data by Type
10.2 Middle East and Africa Ezetimibe Breakdown Data by Application
10.3 Middle East and Africa Ezetimibe Breakdown Data by Countries
10.3.1 Middle East and Africa Ezetimibe Sales by Countries
10.3.2 Middle East and Africa Ezetimibe Revenue by Countries
10.3.3 GCC Countries
10.3.4 Egypt
10.3.5 South Africa

11 Company Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Ezetimibe
11.1.4 Ezetimibe Product Introduction
11.1.5 Merck Recent Development
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Ezetimibe
11.2.4 Ezetimibe Product Introduction
11.2.5 Teva Recent Development
11.3 Zydus Pharmaceuticals
11.3.1 Zydus Pharmaceuticals Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Ezetimibe
11.3.4 Ezetimibe Product Introduction
11.3.5 Zydus Pharmaceuticals Recent Development
11.4 Amneal Pharmaceuticals
11.4.1 Amneal Pharmaceuticals Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Ezetimibe
11.4.4 Ezetimibe Product Introduction
11.4.5 Amneal Pharmaceuticals Recent Development
11.5 Alkem Laboratories
11.5.1 Alkem Laboratories Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Ezetimibe
11.5.4 Ezetimibe Product Introduction
11.5.5 Alkem Laboratories Recent Development
11.6 APOTEX
11.6.1 APOTEX Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Ezetimibe
11.6.4 Ezetimibe Product Introduction
11.6.5 APOTEX Recent Development
11.7 Sandoz
11.7.1 Sandoz Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Ezetimibe
11.7.4 Ezetimibe Product Introduction
11.7.5 Sandoz Recent Development
11.8 Glenmark Pharmaceuticals
11.8.1 Glenmark Pharmaceuticals Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Ezetimibe
11.8.4 Ezetimibe Product Introduction
11.8.5 Glenmark Pharmaceuticals Recent Development
11.9 Mylan Pharmaceuticals
11.9.1 Mylan Pharmaceuticals Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Ezetimibe
11.9.4 Ezetimibe Product Introduction
11.9.5 Mylan Pharmaceuticals Recent Development
11.10 Aurobindo Pharma
11.10.1 Aurobindo Pharma Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of Ezetimibe
11.10.4 Ezetimibe Product Introduction
11.10.5 Aurobindo Pharma Recent Development
11.11 Accord Healthcare

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Ezetimibe Sales Channels
12.2.2 Ezetimibe Distributors
12.3 Ezetimibe Customers

13 Market Forecast
13.1 Global Ezetimibe Sales and Revenue Forecast 2018-2025
13.2 Global Ezetimibe Sales Forecast by Type
13.3 Global Ezetimibe Sales Forecast by Application
13.4 Ezetimibe Forecast by Regions
13.4.1 Global Ezetimibe Sales Forecast by Regions 2018-2025
13.4.2 Global Ezetimibe Revenue Forecast by Regions 2018-2025
13.5 North America Market Forecast
13.5.1 North America Ezetimibe Forecast by Countries 2018-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Ezetimibe Forecast by Countries 2018-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Ezetimibe Sales Forecast by Countries 2018-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Ezetimibe Sales Forecast by Countries 2018-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Ezetimibe Sales Forecast by Countries 2018-2025
13.9.2 GCC Countries
13.9.3 Egypt
13.9.4 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Ezetimibe Product Picture
Table Ezetimibe Key Market Segments
Table Major Manufacturers Ezetimibe Covered in This Report
Table Global Ezetimibe Market Size Growth Rate by Type 2018-2025 (K Units) & (Million US$)
Figure Global Ezetimibe Sales Market Shar by Type 2013-2025
Figure 10 mg tablet Figures
Table Major Manufacturers of 10 mg tablet
Figure Type II Figures
Table Major Manufacturers of Type II
Table Global Ezetimibe Market Share by Application 2018-2025 (K Units)
Figure Adult Use Case
Figure Children(10-17 years) Use Case
Figure Ezetimibe Report Years Considered
Figure Global Ezetimibe Market Size 2013-2025 (Million US$)
Figure Global Ezetimibe Sales 2013-2018 (K Units)
Table Global Ezetimibe Market Size by Regions 2013-2018 (K Units) & (Million US$)
Table Global Ezetimibe Sales by Regions 2013-2018 (K Units)
Table Global Ezetimibe Sales Market Share by Regions 2013-2018
Figure Global Ezetimibe Sales Market Share by Regions 2013-2018
Figure Global Ezetimibe Sales Market Share by Regions in 2018
Table Global Ezetimibe Revenue by Regions 2013-2018 (Million US$)
Table Global Ezetimibe Revenue Market Share by Regions 2013-2018
Figure Global Ezetimibe Revenue Market Share by Regions 2013-2018
Figure Global Ezetimibe Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Ezetimibe Sales by Manufacturers (2013-2018) (K Units)
Table Global Ezetimibe Sales Share by Manufacturers (2013-2018)
Figure Global Ezetimibe Sales Share by Manufacturers in 2018
Table Ezetimibe Revenue by Manufacturers (2013-2018) (Million USD)
Table Ezetimibe Revenue Share by Manufacturers (2013-2018)
Figure Ezetimibe Value Share by Manufacturers in 2018
Table Global Ezetimibe Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Ezetimibe Price (2013-2018) (USD/Unit)
Table Key Manufacturers Ezetimibe Plants/Factories Distribution
Table Key Manufacturers Ezetimibe Area Served
Table Date of Key Manufacturers Enter into Ezetimibe Market
Table Key Manufacturers Ezetimibe Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global 10 mg tablet Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Type II Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Ezetimibe Sales by Type (2013-2018) (K Units)
Table Global Ezetimibe Sales Share by Type (2013-2018)
Figure Global Ezetimibe Sales Market Share by Type (2013-2018)
Figure Global Ezetimibe Sales Market Share by Type in 2017
Table Global Ezetimibe Revenue by Type (2013-2018) (Million US$)
Table Global Ezetimibe Revenue Share by Type (2013-2018)
Figure Global Ezetimibe Revenue Market Share by Type (2013-2018)
Figure Global Ezetimibe Revenue Market Share by Type in 2017
Table Ezetimibe Price by Type 2013-2018 (USD/Unit)
Table Global Ezetimibe Sales by Application (2013-2018) (K Units)
Table Global Ezetimibe Sales Share by Application (2013-2018)
Figure Global Sales Ezetimibe Market Share by Application (2013-2018)
Figure Global Sales Ezetimibe Market Share by Application in 2017
Figure North America Ezetimibe Sales Growth Rate 2013-2018 (K Units)
Figure North America Ezetimibe Revenue Growth Rate 2013-2018 (Million US$)
Table North America Ezetimibe Sales by Company (2013-2018) (K Units)
Table North America Ezetimibe Sales Market Share by Company (2013-2018)
Figure North America Ezetimibe Sales Market Share by Company in 2018
Table North America Ezetimibe Sales by Type (2013-2018) (K Units)
Table North America Ezetimibe Sales Market Share by Type (2013-2018)
Figure North America Ezetimibe Market Share by Type in 2018
Table North America Ezetimibe Sales by Application (2013-2018) (K Units)
Table North America Ezetimibe Sales Market Share by Application (2013-2018)
Figure North America Ezetimibe Market Share by Application in 2018
Table North America Ezetimibe Sales by Countries (2013-2018) (K Units)
Table North America Ezetimibe Sales Market Share by Countries (2013-2018)
Figure 2017 North America Ezetimibe Sales Market Share by Countries
Table North America Ezetimibe Revenue by Countries (2013-2018) (Million US$)
Table North America Ezetimibe Revenue Market Share by Countries (2013-2018)
Figure 2017 North America Ezetimibe Revenue Market Share by Countries
Figure United States Ezetimibe Sales Growth Rate (2013-2018) (K Units)
Figure Canada Ezetimibe Sales Growth Rate (2013-2018) (K Units)
Figure Mexico Ezetimibe Sales Growth Rate (2013-2018) (K Units)
Figure Europe Ezetimibe Sales Growth Rate 2013-2018 (K Units)
Figure Europe Ezetimibe Revenue Growth Rate 2013-2018 (Million US$)
Table Europe Ezetimibe Sales by Company (2013-2018) (K Units)
Table Europe Ezetimibe Sales Market Share by Company (2013-2018)
Figure Europe Ezetimibe Sales Market Share by Company in 2018
Table Europe Ezetimibe Sales by Type (2013-2018) (K Units)
Table Europe Ezetimibe Sales Market Share by Type (2013-2018)
Figure 2017 Europe Ezetimibe Market Share by Type
Table Europe Ezetimibe Sales by Application (2013-2018) (K Units)
Table Europe Ezetimibe Sales Market Share by Application (2013-2018)
Figure 2017 Europe Ezetimibe Market Share by Application
Table Europe Ezetimibe Sales by Countries (2013-2018) (K Units)
Table Europe Ezetimibe Sales Market Share by Countries (2013-2018)
Figure 2017 Europe Ezetimibe Sales Market Share by Countries
Table Europe Ezetimibe Revenue by Countries (2013-2018) (Million US$)
Table Europe Ezetimibe Revenue Market Share by Countries (2013-2018)
Figure Europe Ezetimibe Revenue Market Share by Countries in 2018
Figure Germany Ezetimibe Sales Growth Rate (2013-2018) (K Units)
Figure France Ezetimibe Sales Growth Rate (2013-2018) (K Units)
Figure UK Ezetimibe Sales Growth Rate (2013-2018) (K Units)
Figure Italy Ezetimibe Sales Growth Rate (2013-2018) (K Units)
Figure Russia Ezetimibe Sales Growth Rate (2013-2018) (K Units)
Figure Asia Pacific Ezetimibe Sales Growth Rate 2013-2018 (K Units)
Figure Asia Pacific Ezetimibe Revenue Growth Rate 2013-2018 (Million US$)
Table Asia Pacific Ezetimibe Sales by Company (2013-2018) (K Units)
Table Asia Pacific Ezetimibe Sales Market Share by Company (2013-2018)
Figure Asia Pacific Ezetimibe Sales Market Share by Company in 2018
Table Asia Pacific Ezetimibe Sales by Type (2013-2018) (K Units)
Table Asia Pacific Ezetimibe Sales Market Share by Type (2013-2018)
Figure Asia Pacific Ezetimibe Market Share by Type in 2018
Table Asia Pacific Ezetimibe Sales by Application (2013-2018) (K Units)
Table Asia Pacific Ezetimibe Sales Market Share by Application (2013-2018)
Figure Asia Pacific Ezetimibe Market Share by Application in 2018
Table Asia Pacific Ezetimibe Sales by Countries (2013-2018) (K Units)
Table Asia Pacific Ezetimibe Sales Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Ezetimibe Sales Market Share by Countries
Table Asia Pacific Ezetimibe Revenue by Countries (2013-2018) (Million US$)
Table Asia Pacific Ezetimibe Revenue Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Ezetimibe Revenue Market Share by Countries
Figure China Ezetimibe Sales Growth Rate (2013-2018) (K Units)
Figure China Ezetimibe Revenue Growth Rate (2013-2018) (Million US$)
Figure Japan Ezetimibe Sales Growth Rate (2013-2018) (K Units)
Figure Japan Ezetimibe Revenue Growth Rate (2013-2018) (Million US$)
Figure Korea Ezetimibe Sales Growth Rate (2013-2018) (K Units)
Figure Korea Ezetimibe Revenue Growth Rate (2013-2018) (Million US$)
Figure India Ezetimibe Sales Growth Rate (2013-2018) (K Units)
Figure India Ezetimibe Revenue Growth Rate (2013-2018) (Million US$)
Figure Australia Ezetimibe Sales Growth Rate (2013-2018) (K Units)
Figure Australia Ezetimibe Revenue Growth Rate (2013-2018) (Million US$)
Figure Indonesia Ezetimibe Sales Growth Rate (2013-2018) (K Units)
Figure Indonesia Ezetimibe Revenue Growth Rate (2013-2018) (Million US$)
Figure Malaysia Ezetimibe Sales Growth Rate (2013-2018) (K Units)
Figure Malaysia Ezetimibe Revenue Growth Rate (2013-2018) (Million US$)
Figure Philippines Ezetimibe Sales Growth Rate (2013-2018) (K Units)
Figure Philippines Ezetimibe Revenue Growth Rate (2013-2018) (Million US$)
Figure Thailand Ezetimibe Sales Growth Rate (2013-2018) (K Units)
Figure Thailand Ezetimibe Revenue Growth Rate (2013-2018) (Million US$)
Figure Vietnam Ezetimibe Sales Growth Rate (2013-2018) (K Units)
Figure Vietnam Ezetimibe Revenue Growth Rate (2013-2018) (Million US$)
Figure Central & South America Ezetimibe Sales Growth Rate 2013-2018 (K Units)
Figure Central & South America Ezetimibe Revenue Growth Rate 2013-2018 (Million US$)
Table Central & South America Ezetimibe Sales by Company (2013-2018) (K Units)
Table Central & South America Ezetimibe Sales Market Share by Company (2013-2018)
Figure Central & South America Ezetimibe Sales Market Share by Company in 2018
Table Central & South America Ezetimibe Sales by Type (2013-2018) (K Units)
Table Central & South America Ezetimibe Sales Market Share by Type (2013-2018)
Figure Central & South America Ezetimibe Market Share by Type in 2018
Table Central & South America Ezetimibe Sales by Application (2013-2018) (K Units)
Table Central & South America Ezetimibe Sales Market Share by Application (2013-2018)
Figure Central & South America Ezetimibe Market Share by Application in 2018
Table Central & South America Ezetimibe Sales by Countries (2013-2018) (K Units)
Table Central & South America Ezetimibe Sales Market Share by Countries (2013-2018)
Figure Central & South America Ezetimibe Sales Market Share by Countries in 2018
Table Central & South America Ezetimibe Revenue by Countries (2013-2018) (Million US$)
Table Central & South America Ezetimibe Revenue Market Share by Countries (2013-2018)
Figure Central & South America Ezetimibe Revenue Market Share by Countries in 2018
Figure Brazil Ezetimibe Sales Growth Rate (2013-2018) (K Units)
Figure Brazil Ezetimibe Revenue Growth Rate (2013-2018) (K Units)
Figure Middle East and Africa Ezetimibe Sales Growth Rate 2013-2018 (K Units)
Figure Middle East and Africa Ezetimibe Revenue Growth Rate 2013-2018 (Million US$)
Table Middle East and Africa Ezetimibe Sales by Type (2013-2018) (K Units)
Table Middle East and Africa Ezetimibe Sales Market Share by Type (2013-2018)
Figure 2017 Middle East and Africa Ezetimibe Market Share by Type
Table Middle East and Africa Ezetimibe Sales by Application (2013-2018) (K Units)
Table Middle East and Africa Ezetimibe Sales Market Share by Application (2013-2018)
Figure 2017 Middle East and Africa Ezetimibe Market Share by Application
Table Middle East and Africa Ezetimibe Sales by Countries (2013-2018) (K Units)
Table Middle East and Africa Ezetimibe Sales Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Ezetimibe Sales Market Share by Countries
Table Middle East and Africa Ezetimibe Revenue by Countries (2013-2018) (Million US$)
Table Middle East and Africa Ezetimibe Revenue Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Ezetimibe Revenue Market Share by Countries
Figure GCC Countries Ezetimibe Sales Growth Rate (2013-2018) (K Units)
Figure GCC Countries Ezetimibe Revenue Growth Rate (2013-2018) (K Units)
Figure Egypt Ezetimibe Sales Growth Rate (2013-2018) (K Units)
Figure Egypt Ezetimibe Revenue Growth Rate (2013-2018) (K Units)
Figure South Africa Ezetimibe Sales Growth Rate (2013-2018) (K Units)
Figure South Africa Ezetimibe Revenue Growth Rate (2013-2018) (K Units)
Table Merck Company Details
Table Merck Description and Business Overview
Table Merck Ezetimibe Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Merck Ezetimibe Sales Growth Rate (2013-2018)
Table Merck Ezetimibe Sales Market Share in Global Market
Table Merck Recent Development
Table Teva Company Details
Table Teva Description and Business Overview
Table Teva Ezetimibe Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Teva Ezetimibe Sales Growth Rate (2013-2018)
Table Teva Ezetimibe Sales Market Share in Global Market
Table Teva Recent Development
Table Zydus Pharmaceuticals Company Details
Table Zydus Pharmaceuticals Description and Business Overview
Table Zydus Pharmaceuticals Ezetimibe Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Zydus Pharmaceuticals Ezetimibe Sales Growth Rate (2013-2018)
Table Zydus Pharmaceuticals Ezetimibe Sales Market Share in Global Market
Table Zydus Pharmaceuticals Recent Development
Table Amneal Pharmaceuticals Company Details
Table Amneal Pharmaceuticals Description and Business Overview
Table Amneal Pharmaceuticals Ezetimibe Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Amneal Pharmaceuticals Ezetimibe Sales Growth Rate (2013-2018)
Table Amneal Pharmaceuticals Ezetimibe Sales Market Share in Global Market
Table Amneal Pharmaceuticals Recent Development
Table Alkem Laboratories Company Details
Table Alkem Laboratories Description and Business Overview
Table Alkem Laboratories Ezetimibe Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Alkem Laboratories Ezetimibe Sales Growth Rate (2013-2018)
Table Alkem Laboratories Ezetimibe Sales Market Share in Global Market
Table Alkem Laboratories Recent Development
Table APOTEX Company Details
Table APOTEX Description and Business Overview
Table APOTEX Ezetimibe Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table APOTEX Ezetimibe Sales Growth Rate (2013-2018)
Table APOTEX Ezetimibe Sales Market Share in Global Market
Table APOTEX Recent Development
Table Sandoz Company Details
Table Sandoz Description and Business Overview
Table Sandoz Ezetimibe Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Sandoz Ezetimibe Sales Growth Rate (2013-2018)
Table Sandoz Ezetimibe Sales Market Share in Global Market
Table Sandoz Recent Development
Table Glenmark Pharmaceuticals Company Details
Table Glenmark Pharmaceuticals Description and Business Overview
Table Glenmark Pharmaceuticals Ezetimibe Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Glenmark Pharmaceuticals Ezetimibe Sales Growth Rate (2013-2018)
Table Glenmark Pharmaceuticals Ezetimibe Sales Market Share in Global Market
Table Glenmark Pharmaceuticals Recent Development
Table Mylan Pharmaceuticals Company Details
Table Mylan Pharmaceuticals Description and Business Overview
Table Mylan Pharmaceuticals Ezetimibe Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Mylan Pharmaceuticals Ezetimibe Sales Growth Rate (2013-2018)
Table Mylan Pharmaceuticals Ezetimibe Sales Market Share in Global Market
Table Mylan Pharmaceuticals Recent Development
Table Aurobindo Pharma Company Details
Table Aurobindo Pharma Description and Business Overview
Table Aurobindo Pharma Ezetimibe Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Aurobindo Pharma Ezetimibe Sales Growth Rate (2013-2018)
Table Aurobindo Pharma Ezetimibe Sales Market Share in Global Market
Table Aurobindo Pharma Recent Development
Table Accord Healthcare Company Details
Figure Ezetimibe Value Chain
Table Ezetimibe Distributors List
Table Ezetimibe Customers List
Table Global Ezetimibe Sales Forecast 2018-2025 (K Units) & (Million US$)
Figure Global Ezetimibe Sales Forecast 2018-2025 (K Units)
Figure Global Ezetimibe Revenue Forecast 2018-2025 (Million US$)
Table Global Ezetimibe Sales Forecast by Type 2018-2025 (K Units)
Figure Global Ezetimibe Sales Forecast by Type 2018-2025 (K Units)
Figure Global Ezetimibe Sales Market Share Forecast by Type 2018-2025
Table Global Ezetimibe Sales Forecast by Application 2018-2025 (K Units)
Figure Global Ezetimibe Sales Forecast by Application 2018-2025 (K Units)
Figure Global Ezetimibe Sales Market Share Forecast by Application 2018-2025
Table Global Ezetimibe Sales Forecast by Regions 2018-2025 (K Units)
Figure Global Ezetimibe Sales Forecast by Regions 2018-2025 (K Units)
Figure Global Ezetimibe Sales Market Share Forecast by Regions 2018-2025
Table Global Ezetimibe Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global Ezetimibe Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global Ezetimibe Revenue Market Share Forecast by Regions 2018-2025
Table North America Ezetimibe Sales Forecast by Countries 2018-2025 (K Units)
Table North America Ezetimibe Sales Market Share Forecast by Countries 2018-2025
Table North America Ezetimibe Revenue Forecast by Countries 2018-2025 (Million US$)
Table North America Ezetimibe Revenue Market Share Forecast by Countries 2018-2025
Figure United States Ezetimibe Sales Forecast 2018-2025 (K Units)
Figure Canada Ezetimibe Sales Forecast 2018-2025 (K Units)
Figure MexicoEzetimibe Sales Forecast 2018-2025 (K Units)
Table Europe Ezetimibe Sales Forecast by Countries 2018-2025 (K Units)
Table Europe Ezetimibe Sales Market Share Forecast by Countries 2018-2025
Table Europe Ezetimibe Revenue Forecast by Countries 2018-2025 (Million US$)
Table Europe Ezetimibe Revenue Market Share Forecast by Countries 2018-2025
Figure Germany Ezetimibe Sales Forecast 2018-2025 (K Units)
Figure France Ezetimibe Sales Forecast 2018-2025 (K Units)
Figure UK Ezetimibe Sales Forecast 2018-2025 (K Units)
Figure Italy Ezetimibe Sales Forecast 2018-2025 (K Units)
Figure Russia Ezetimibe Sales Forecast 2018-2025 (K Units)
Table Asia Pacific Ezetimibe Sales Forecast by Countries 2018-2025 (K Units)
Table Asia Pacific Ezetimibe Sales Market Share Forecast by Countries 2018-2025
Table Asia Pacific Ezetimibe Revenue Forecast by Countries 2018-2025 (Million US$)
Table Asia Pacific Ezetimibe Revenue Market Share Forecast by Countries 2018-2025
Figure China Ezetimibe Sales Forecast 2018-2025 (K Units)
Figure Japan Ezetimibe Sales Forecast 2018-2025 (K Units)
Figure Korea Ezetimibe Sales Forecast 2018-2025 (K Units)
Figure India Ezetimibe Sales Forecast 2018-2025 (K Units)
Figure Australia Ezetimibe Sales Forecast 2018-2025 (K Units)
Figure Indonesia Ezetimibe Sales Forecast 2018-2025 (K Units)
Figure Thailand Ezetimibe Sales Forecast 2018-2025 (K Units)
Figure Malaysia Ezetimibe Sales Forecast 2018-2025 (K Units)
Figure Philippines Ezetimibe Sales Forecast 2018-2025 (K Units)
Figure Vietnam Ezetimibe Sales Forecast 2018-2025 (K Units)
Table Central & South America Ezetimibe Sales Forecast by Countries 2018-2025 (K Units)
Table Central & South America Ezetimibe Sales Market Share Forecast by Countries 2018-2025
Table Central & South America Ezetimibe Revenue Forecast by Countries 2018-2025 (Million US$)
Table Central & South America Ezetimibe Revenue Market Share Forecast by Countries 2018-2025
Figure Brazil Ezetimibe Sales Forecast 2018-2025 (K Units)
Table Middle East and Africa Ezetimibe Sales Forecast by Regions 2018-2025 (K Units)
Table Middle East and Africa Ezetimibe Sales Market Share Forecast by Regions 2018-2025
Table Middle East and Africa Ezetimibe Revenue Forecast by Regions 2018-2025 (Million US$)
Table Middle East and Africa Ezetimibe Revenue Market Share Forecast by Regions 2018-2025
Figure GCC Countries Ezetimibe Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Ezetimibe Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Ezetimibe Sales Growth Rate (2016-2025) (K Units)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Merck、Teva、Zydus Pharmaceuticals、Amneal Pharmaceuticals、Alkem Laboratories、APOTEX、Sandoz、Glenmark Pharmaceuticals、Mylan Pharmaceuticals、Aurobindo Pharma、Accord Healthcare

★調査レポート[エゼチミブの世界市場動向・分析2018-2025] (コード：QYR8D03662)販売に関する免責事項を必ずご確認ください。
★調査レポート[エゼチミブの世界市場動向・分析2018-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • エゼチミブ・シンバスタチンの世界市場動向・分析2018-2025
    QYR8D03663 / QYResearch / 2018年11月12日 / 本調査レポートは、エゼチミブ・シンバスタチンの世界市場について調査・分析し、種類別には、10/10タブレット、10/20タブレット、10/40タブレットに、用途別には、大人、子ども(10-17歳)に区分してまとめました。調査対象企業は、Merck、Teva、Dr. Reddy's Laboratories、ANI Pharmaceuticals、Amneal Pharmaceuticals、Alkem Laboratories、Mylan等です。 ・レポートの概要 ・グローバル成長トレンド ・エゼチミブ・シンバスタチンの世界市場規模 ・エゼチミブ・シンバスタチンの地域別市場規模...This combination medication is used along with a proper diet to help lower "bad" cholesterol and fats (such as LDL, triglycerides) and raise "good" cholesterol (HDL) in the blood. Ezetimibe works by reducing the amount of cholesterol your body absorbs from your diet. Simvastatin belongs to a group of drugs known as "statins." It works by reducing the amount of cholesterol made by the liver.In 2018, the global Ezetimibe and Simvastatin market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been...
  • 塩酸フルナリジンの世界市場動向・分析2018-2025
    QYR8D03998 / QYResearch / 2018年10月31日 / 本調査レポートは、塩酸フルナリジンの世界市場について調査・分析し、種類別には、タブレット、カプセルに、用途別には、病院、クリニック、クリニック機関、学術研究、その他に区分してまとめました。調査対象企業は、Johnson and Johnson、Cipla Limited、Torrent Pharmaceuticals Ltd、Aa Pharma Inc、Karnataka Antibiotics and...Flunarizine hydrochloride is a calcium antagonist drug that acts by reducing or preventing migraine headaches. This drug is used to treat dizziness and vertigo.Growth in the prevalence of migraine, increasing consumption of junk food, smoking and drinking, and hectic and stressful lifestyle that leads to migraines drive the flunarizine hydrochloride market growth. In 2018, the global Flunarizine Hydrochloride market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period...
  • アセタゾラミドの世界市場動向・分析2018-2025
    QYR8D00043 / QYResearch / 2018年11月27日 / 本調査レポートは、アセタゾラミドの世界市場について調査・分析し、種類別には、タブレット、カプセル、吸引に、用途別には、病院、薬局に区分してまとめました。調査対象企業は、Teva、TARO、Zydus Pharmaceuticals、Lannett Company、Sun Pharmaceutical、Heritage Pharmaceuticals、Nostrum Laboratories、Accord Healthcare、Strides Pharma、West-Ward Pharmaceuticals、X-Gen Pharmaceuticals、Mylan、Emcure等です。...Acetazolamide, sold under the trade name Diamox among others, is a medication used to treat glaucoma, epilepsy, altitude sickness, periodic paralysis, idiopathic intracranial hypertension, and heart failure. It may be used long term for the treatment of open angle glaucoma and short term for acute angle closure glaucoma until surgery can be carried out. It is taken by mouth or injection into a vein.In 2018, the global Acetazolamide market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the...
  • フェノフィブラートの世界市場動向・分析2018-2025
    QYR8D03731 / QYResearch / 2018年11月27日 / 本調査レポートは、フェノフィブラートの世界市場について調査・分析し、種類別には、タブレット、カプセルに、用途別には、病院、薬局に区分してまとめました。調査対象企業は、AbbVie、Lupin、Salix Pharmaceuticals、Vectura、Cipher Pharmaceuticals、Rhodes Pharmaceuticals、Impax Laboratories、Mylan、Teva、Sun Pharmaceutical、Bausch Health、HETERO、Aurobindo Pharma、Cipla、Amneal Pharmaceuticals、Prinston Pharmaceutical、Dr....Fenofibrate, marketed as Tricor and under several other brand names, is a drug of the fibrate class. It is mainly used to reduce cholesterol levels in people at risk of cardiovascular disease. Like other fibrates, it reduces both low-density lipoprotein (LDL) and very low density lipoprotein (VLDL) levels, as well as increasing high-density lipoprotein (HDL) levels and reducing triglyceride levels.In 2018, the global Fenofibrate market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018...
  • カンデサルタンシレキセチル薬の世界市場動向・分析2018-2025
    QYR8D01581 / QYResearch / 2018年11月1日 / 本調査レポートは、カンデサルタンシレキセチル薬の世界市場について調査・分析し、種類別には、4mgタブレット、8mgタブレット、16mgタブレット、32mgタブレットに、用途別には、大人のEssential高血圧、子どもの高血圧6歳...Candesartan cilexetil (candesartan) is a drug used for treating high blood pressure (hypertension). It is in a class of drugs called angiotensin receptor blockers (ARBs) which includes losartan (Cozaar), valsartan (Diovan), and irbesartan (Avapro). Angiotensin, formed in the blood by the action of angiotensin converting enzyme (ACE), is a powerful chemical that attaches to angiotensin receptors found in many tissues but primarily on smooth muscle cells surrounding blood vessels. Angiotensin's attachment to the receptors causes the muscle cells to contract and the blood vessels to narrow (vasoconstrict) which leads to an increase in blood pressure. Candesartan blocks the angiotensin receptor...
  • アミオダロンの世界市場動向・分析2018-2025
    QYR8D00388 / QYResearch / 2018年11月19日 / 本調査レポートは、アミオダロンの世界市場について調査・分析し、種類別には、タブレット、カプセル、注入に、用途別には、心停止、心室頻拍、心房細動、その他に区分してまとめました。調査対象企業は、Sanofi、Sawai Pharmaceutical、Wyeth Pharmaceuticals (Pfizer)、Mylan Pharmaceuticals、Arrow Pharma Pty Ltd、Roemmers、Cipla Pharmaceutical、Shanghai Pharmaceuticals、North...Amiodarone is an antiarrhythmic medication used to treat and prevent a number of types of irregular heartbeats. This includes ventricular tachycardia (VT), ventricular fibrillation (VF), and wide complex tachycardia, as well as atrial fibrillation and paroxysmal supraventricular tachycardia.In 2018, the global Amiodarone market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Amiodarone. This study researches the market size of Amiodarone, presents...
  • アシクロビル薬の世界市場動向・分析2018-2025
    QYR8D00094 / QYResearch / 2018年11月27日 / 本調査レポートは、アシクロビル薬の世界市場について調査・分析し、種類別には、経口、外用、注入に、用途別には、病院、薬局に区分してまとめました。調査対象企業は、GSK、Zydus Pharmaceuticals、Mylan、Bausch Health、Vectans Pharma、Fresenius Kabi、Aurobindo Pharma、Teva、Heritage Pharmaceuticals、APOTEX、Cadila Pharmaceuticals、Amneal Pharmaceuticals、TARO、Glenmark、G&W Laboratories、Yiling...Acyclovir is used to treat infections caused by herpes viruses.In 2018, the global Acyclovir Drug market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Acyclovir Drug. This study researches the market size of Acyclovir Drug, presents the global Acyclovir Drug sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025. This...
  • フルクロキサシリンの世界市場動向・分析2018-2025
    QYR8D03988 / QYResearch / 2018年12月6日 / 本調査レポートは、フルクロキサシリンの世界市場について調査・分析し、種類別には、純度:≥95%、純度:≥99%に、用途別には、注入商品、テーブル商品、その他に区分してまとめました。調査対象企業は、Syschem、Canagen Pharmaceuticals Inc、Asiatic Drugs＆Pharmaceuticals、Genesisny、Vaishali、Vysali、Shree Nath Life Sciences、G.G. Chemicals & Pharmaceuticals...Flucloxacillin is a semi-synthetic penicillin-resistant penicillinIn 2018, the global Flucloxacillin market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Flucloxacillin. This study researches the market size of Flucloxacillin, presents the global Flucloxacillin sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025. This report focuses on the key data information of...
  • バルビツール酸薬の世界市場動向・分析2018-2025
    QYR8D01109 / QYResearch / 2018年12月7日 / 本調査レポートは、バルビツール酸薬の世界市場について調査・分析し、種類別には、ウルトラ-ショートアクティングバルビツール酸、ショートアクティングバルビツール酸、長時間作用バルビツール酸、コンビネーション薬に、用途別には、病院薬局、小売薬局、オンライン薬局に区分してまとめました。調査対象企業は、Pfizer、Merck、Eli Lilly、Mylan、Sanofi、Teva Pharmaceutical、Sumitomo Dainippon Pharma、Valeant Pharmaceuticals、Oak Pharmaceuticals、Meda pharmaceuticals等です。 ・レポートの概要 ・グローバル成長トレンド...Barbiturates act as central nervous system depressants. Barbiturates are derivatives of a chemical called barbituric acid. Various barbiturate drugs are available in the market; however, all have sedative effect on the central nervous system and are clinically prescribed for anxiety. Barbiturates are also used in the treatment of epilepsy, insomnia, and status epilepticus. Barbiturate drugs are available in pill form and can be taken orally and intravenously.Barbiturates are subjected to the Drug Abuse Prevention and Control Act in the U.S. Hence, manufacture and distribution of these drugs are strictly controlled. Barbiturate drugs act by enhancing the activity of one of...
  • BFSの世界市場動向・分析2018-2025
    QYR8D01347 / QYResearch / 2018年12月7日 / 本調査レポートは、BFSの世界市場について調査・分析し、種類別には、PE、PP、その他に、用途別には、医薬品、食品・飲料、コスメティクス・パーソナルケア、その他に区分してまとめました。調査対象企業は、Unither Pharmaceuticals、Nephron Pharmaceuticals、Takeda Pharmaceuticals、Recipharm、TRC、SIFI、Catalent、Horizon Pharmaceuticals、Unicep Packaging、Amanta Healthcare、CR Double-Crane、SALVAT、Unipharma、Asept Pak、Pharmapack、Curida等です。 ・レポートの概要...BFS (Blow-Fill-Seal) technology is a manufacturing technique used to produce small, (0.1mL) and large volume, (500mL +) liquid-filled containers. Originally developed in Europe in the 1930s, it was introduced in the United States in the 1960s, but over the last 20 years it has become more prevalent within the pharmaceutical industry and is now widely considered to be the superior form of aseptic processing by various medicine regulatory agencies including the US Food and Drug Administration (FDA) in the packaging of pharmaceutical and healthcare products.The Blow Fill Seal (BFS) market was valued at xx Million US$ in 2017 and is...

    • ◆H&Iグローバルリサーチのお客様（例）◆